Cure My Disease

Don't miss your cure!

 Log in / Sign up

New implant aims to fuse arthritic finger joints and ease pain

NCT ID NCT06546332

Ongoing Disease control Sponsor: Keri Medical SA Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing a device called KeriFuse® that is implanted into the finger joint to fuse the bones together. It is for people with arthritis in the last joint of the finger or thumb. The goal is to see if it reduces pain and successfully fuses the joint within three months. About 97 adults are taking part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
KeriFuse® intramedullary arthrodesis implant (a device to fuse finger joints)
What this could lead to
If successful, this implant could provide a reliable option to reduce pain and restore stability in arthritic finger joints.
What could go wrong
This is a post-market study with no control group, so results may not prove superiority over other treatments. Risks include infection, implant failure, or incomplete bone fusion.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arthritic joint disease osteoarthritis, hand

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTHRITIS

Contacts and locations

Locations

  • Centre Ostéo Articulaire Fleming

    Bourgoin, 38300, France

  • Centre de la main du Pays d'Aix

    Aix-en-Provence, 13090, France

  • Clinique Mutualiste Catalane

    Perpignan, 66000, France

  • Clinique Saint François

    Nice, 06000, France

  • Clinique de la Chataigneraie

    Beaumont, 63110, France

  • Clinique du Parc

    Périgueux, 24000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.